nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—Post procedural haemorrhage—Indomethacin—gout	0.0424	0.0773	CcSEcCtD
Ruxolitinib—BMP2K—synovial membrane of synovial joint—gout	0.0367	0.175	CbGeAlD
Ruxolitinib—Haemorrhage intracranial—Indomethacin—gout	0.0226	0.0412	CcSEcCtD
Ruxolitinib—Myelosuppression—Colchicine—gout	0.0208	0.0379	CcSEcCtD
Ruxolitinib—Tuberculosis—Prednisone—gout	0.0155	0.0283	CcSEcCtD
Ruxolitinib—PRKCE—tendon—gout	0.0121	0.0575	CbGeAlD
Ruxolitinib—RPS6KA6—tendon—gout	0.0116	0.0553	CbGeAlD
Ruxolitinib—Haematuria—Probenecid—gout	0.0109	0.0198	CcSEcCtD
Ruxolitinib—IRAK1—IL1 and megakaryotyces in obesity—NLRP3—gout	0.0104	0.0431	CbGpPWpGaD
Ruxolitinib—Herpes zoster—Naproxen—gout	0.00975	0.0178	CcSEcCtD
Ruxolitinib—Contusion—Allopurinol—gout	0.00964	0.0176	CcSEcCtD
Ruxolitinib—CAMK1—tendon—gout	0.00905	0.0432	CbGeAlD
Ruxolitinib—MARK2—tendon—gout	0.00879	0.0419	CbGeAlD
Ruxolitinib—Anaemia—Probenecid—gout	0.00822	0.015	CcSEcCtD
Ruxolitinib—TAOK2—tendon—gout	0.00813	0.0388	CbGeAlD
Ruxolitinib—Hypercholesterolaemia—Naproxen—gout	0.00776	0.0141	CcSEcCtD
Ruxolitinib—Bone pain—Naproxen—gout	0.00766	0.014	CcSEcCtD
Ruxolitinib—JAK1—tendon—gout	0.00743	0.0354	CbGeAlD
Ruxolitinib—DCLK1—tendon—gout	0.00743	0.0354	CbGeAlD
Ruxolitinib—CAMK1D—tendon—gout	0.00725	0.0345	CbGeAlD
Ruxolitinib—PHKG2—tendon—gout	0.00721	0.0343	CbGeAlD
Ruxolitinib—DAPK2—tendon—gout	0.00709	0.0338	CbGeAlD
Ruxolitinib—Gastrointestinal haemorrhage—Colchicine—gout	0.00708	0.0129	CcSEcCtD
Ruxolitinib—STK16—tendon—gout	0.00697	0.0332	CbGeAlD
Ruxolitinib—HIPK2—tendon—gout	0.00693	0.033	CbGeAlD
Ruxolitinib—Gastrointestinal haemorrhage—Indomethacin—gout	0.00673	0.0123	CcSEcCtD
Ruxolitinib—DAPK3—tendon—gout	0.00666	0.0317	CbGeAlD
Ruxolitinib—CLK2—tendon—gout	0.0066	0.0314	CbGeAlD
Ruxolitinib—PHKG2—Carbohydrate metabolism—PRPS1—gout	0.00654	0.0271	CbGpPWpGaD
Ruxolitinib—PHKG2—Carbohydrate metabolism—PRPS2—gout	0.00654	0.0271	CbGpPWpGaD
Ruxolitinib—PRKG2—Hemostasis—LRRC16A—gout	0.00649	0.0269	CbGpPWpGaD
Ruxolitinib—Alanine aminotransferase increased—Colchicine—gout	0.00624	0.0114	CcSEcCtD
Ruxolitinib—MAP3K3—IL1-mediated signaling events—CASP1—gout	0.00623	0.0258	CbGpPWpGaD
Ruxolitinib—BMPR2—tendon—gout	0.00621	0.0296	CbGeAlD
Ruxolitinib—Gastrointestinal haemorrhage—Allopurinol—gout	0.0061	0.0111	CcSEcCtD
Ruxolitinib—MAP3K3—IL1-mediated signaling events—IL1RN—gout	0.00604	0.025	CbGpPWpGaD
Ruxolitinib—Pancytopenia—Colchicine—gout	0.00581	0.0106	CcSEcCtD
Ruxolitinib—IRAK1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NLRP3—gout	0.00579	0.024	CbGpPWpGaD
Ruxolitinib—PLK3—Direct p53 effectors—CASP1—gout	0.00577	0.0239	CbGpPWpGaD
Ruxolitinib—Body temperature increased—Probenecid—gout	0.00574	0.0105	CcSEcCtD
Ruxolitinib—Neutropenia—Colchicine—gout	0.00572	0.0104	CcSEcCtD
Ruxolitinib—BMP2K—tendon—gout	0.00556	0.0265	CbGeAlD
Ruxolitinib—CAMK2G—tendon—gout	0.00556	0.0265	CbGeAlD
Ruxolitinib—Pancytopenia—Indomethacin—gout	0.00552	0.0101	CcSEcCtD
Ruxolitinib—LRRK2—tendon—gout	0.00551	0.0263	CbGeAlD
Ruxolitinib—MAP3K7—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NLRP3—gout	0.00545	0.0226	CbGpPWpGaD
Ruxolitinib—Gastrointestinal haemorrhage—Naproxen—gout	0.00533	0.00971	CcSEcCtD
Ruxolitinib—MAP3K3—Interleukin-1 signaling—IL1RN—gout	0.0053	0.022	CbGpPWpGaD
Ruxolitinib—Weight increased—Indomethacin—gout	0.00529	0.00964	CcSEcCtD
Ruxolitinib—CAMK2G—IFN-gamma pathway—CASP1—gout	0.00529	0.0219	CbGpPWpGaD
Ruxolitinib—Haematuria—Colchicine—gout	0.0052	0.00948	CcSEcCtD
Ruxolitinib—Pruritus—Probenecid—gout	0.00514	0.00936	CcSEcCtD
Ruxolitinib—Pancytopenia—Allopurinol—gout	0.00501	0.00913	CcSEcCtD
Ruxolitinib—MAP3K7—tendon—gout	0.005	0.0238	CbGeAlD
Ruxolitinib—Haematuria—Indomethacin—gout	0.00494	0.00901	CcSEcCtD
Ruxolitinib—Neutropenia—Allopurinol—gout	0.00493	0.00899	CcSEcCtD
Ruxolitinib—TYK2—tendon—gout	0.00491	0.0234	CbGeAlD
Ruxolitinib—Epistaxis—Indomethacin—gout	0.00489	0.00891	CcSEcCtD
Ruxolitinib—MKNK2—tendon—gout	0.00485	0.0231	CbGeAlD
Ruxolitinib—IRAK1—tendon—gout	0.00485	0.0231	CbGeAlD
Ruxolitinib—Weight increased—Allopurinol—gout	0.0048	0.00875	CcSEcCtD
Ruxolitinib—Dizziness—Probenecid—gout	0.0048	0.00875	CcSEcCtD
Ruxolitinib—RET—tendon—gout	0.00473	0.0225	CbGeAlD
Ruxolitinib—Haemoglobin—Indomethacin—gout	0.00468	0.00852	CcSEcCtD
Ruxolitinib—Haemorrhage—Indomethacin—gout	0.00465	0.00848	CcSEcCtD
Ruxolitinib—TAOK2—MAPK Signaling Pathway—CASP1—gout	0.00464	0.0192	CbGpPWpGaD
Ruxolitinib—Urinary tract infection—Allopurinol—gout	0.00457	0.00833	CcSEcCtD
Ruxolitinib—Headache—Probenecid—gout	0.00455	0.00829	CcSEcCtD
Ruxolitinib—Haematuria—Allopurinol—gout	0.00448	0.00817	CcSEcCtD
Ruxolitinib—JAK2—tendon—gout	0.00447	0.0213	CbGeAlD
Ruxolitinib—Hepatobiliary disease—Allopurinol—gout	0.00445	0.00811	CcSEcCtD
Ruxolitinib—Epistaxis—Allopurinol—gout	0.00444	0.00808	CcSEcCtD
Ruxolitinib—Pancytopenia—Naproxen—gout	0.00437	0.00797	CcSEcCtD
Ruxolitinib—Contusion—Hydrocortisone—gout	0.00436	0.00795	CcSEcCtD
Ruxolitinib—MAP3K3—tendon—gout	0.00431	0.0205	CbGeAlD
Ruxolitinib—Malnutrition—Colchicine—gout	0.00426	0.00777	CcSEcCtD
Ruxolitinib—Haemoglobin—Allopurinol—gout	0.00424	0.00773	CcSEcCtD
Ruxolitinib—Haemorrhage—Allopurinol—gout	0.00422	0.00769	CcSEcCtD
Ruxolitinib—JAK1—IFN-gamma pathway—CASP1—gout	0.00419	0.0174	CbGpPWpGaD
Ruxolitinib—Weight decreased—Naproxen—gout	0.00417	0.00759	CcSEcCtD
Ruxolitinib—JAK2—Factors involved in megakaryocyte development and platelet production—LRRC16A—gout	0.00416	0.0172	CbGpPWpGaD
Ruxolitinib—IRAK1—NOD1/2 Signaling Pathway—CASP1—gout	0.00414	0.0172	CbGpPWpGaD
Ruxolitinib—Urinary tract infection—Naproxen—gout	0.00399	0.00727	CcSEcCtD
Ruxolitinib—Flatulence—Indomethacin—gout	0.00399	0.00727	CcSEcCtD
Ruxolitinib—Anaemia—Colchicine—gout	0.00394	0.00718	CcSEcCtD
Ruxolitinib—TAOK3—tendon—gout	0.00393	0.0187	CbGeAlD
Ruxolitinib—Haematuria—Naproxen—gout	0.00392	0.00714	CcSEcCtD
Ruxolitinib—MAP3K7—NOD1/2 Signaling Pathway—CASP1—gout	0.0039	0.0162	CbGpPWpGaD
Ruxolitinib—Hepatobiliary disease—Naproxen—gout	0.00388	0.00708	CcSEcCtD
Ruxolitinib—Epistaxis—Naproxen—gout	0.00387	0.00706	CcSEcCtD
Ruxolitinib—IRAK1—IL1-mediated signaling events—CASP1—gout	0.00385	0.0159	CbGpPWpGaD
Ruxolitinib—Anaemia—Indomethacin—gout	0.00374	0.00682	CcSEcCtD
Ruxolitinib—IRAK1—IL1-mediated signaling events—IL1RN—gout	0.00373	0.0154	CbGpPWpGaD
Ruxolitinib—Haemoglobin—Naproxen—gout	0.00371	0.00675	CcSEcCtD
Ruxolitinib—Haemorrhage—Naproxen—gout	0.00369	0.00672	CcSEcCtD
Ruxolitinib—Malnutrition—Allopurinol—gout	0.00368	0.0067	CcSEcCtD
Ruxolitinib—Flatulence—Allopurinol—gout	0.00362	0.0066	CcSEcCtD
Ruxolitinib—MAP3K7—IL1-mediated signaling events—CASP1—gout	0.00362	0.015	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—LRRC16A—gout	0.00358	0.0148	CbGpPWpGaD
Ruxolitinib—LRRK2—MAPK Signaling Pathway—CASP1—gout	0.00352	0.0146	CbGpPWpGaD
Ruxolitinib—MAP3K7—IL1-mediated signaling events—IL1RN—gout	0.00351	0.0145	CbGpPWpGaD
Ruxolitinib—Nervous system disorder—Colchicine—gout	0.00341	0.00622	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Colchicine—gout	0.00341	0.00621	CcSEcCtD
Ruxolitinib—Anaemia—Allopurinol—gout	0.0034	0.00619	CcSEcCtD
Ruxolitinib—Skin disorder—Colchicine—gout	0.00338	0.00616	CcSEcCtD
Ruxolitinib—IRAK1—Interleukin-1 signaling—IL1RN—gout	0.00327	0.0135	CbGpPWpGaD
Ruxolitinib—Contusion—Prednisone—gout	0.00325	0.00592	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Indomethacin—gout	0.00324	0.0059	CcSEcCtD
Ruxolitinib—Malnutrition—Naproxen—gout	0.00321	0.00585	CcSEcCtD
Ruxolitinib—Flatulence—Naproxen—gout	0.00316	0.00576	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Allopurinol—gout	0.00311	0.00566	CcSEcCtD
Ruxolitinib—MAP3K7—Interleukin-1 signaling—IL1RN—gout	0.00308	0.0128	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—LRRC16A—gout	0.00302	0.0125	CbGpPWpGaD
Ruxolitinib—Gastrointestinal disorder—Colchicine—gout	0.003	0.00547	CcSEcCtD
Ruxolitinib—Fatigue—Colchicine—gout	0.003	0.00547	CcSEcCtD
Ruxolitinib—Hypercholesterolaemia—Prednisone—gout	0.003	0.00546	CcSEcCtD
Ruxolitinib—Infection—Allopurinol—gout	0.00298	0.00543	CcSEcCtD
Ruxolitinib—Anaemia—Naproxen—gout	0.00297	0.00541	CcSEcCtD
Ruxolitinib—Nervous system disorder—Allopurinol—gout	0.00294	0.00536	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Allopurinol—gout	0.00294	0.00535	CcSEcCtD
Ruxolitinib—Skin disorder—Allopurinol—gout	0.00291	0.00531	CcSEcCtD
Ruxolitinib—Fatigue—Indomethacin—gout	0.00285	0.00519	CcSEcCtD
Ruxolitinib—IRAK1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CASP1—gout	0.00283	0.0117	CbGpPWpGaD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Naproxen—gout	0.00271	0.00494	CcSEcCtD
Ruxolitinib—MAP3K7—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CASP1—gout	0.00266	0.011	CbGpPWpGaD
Ruxolitinib—Body temperature increased—Indomethacin—gout	0.00261	0.00476	CcSEcCtD
Ruxolitinib—Infection—Naproxen—gout	0.0026	0.00474	CcSEcCtD
Ruxolitinib—JAK1—Leptin signaling pathway—IL1RN—gout	0.0026	0.0108	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—LRRC16A—gout	0.0026	0.0108	CbGpPWpGaD
Ruxolitinib—Gastrointestinal disorder—Allopurinol—gout	0.00259	0.00472	CcSEcCtD
Ruxolitinib—Nervous system disorder—Naproxen—gout	0.00257	0.00468	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Naproxen—gout	0.00256	0.00467	CcSEcCtD
Ruxolitinib—ROCK1—Leptin signaling pathway—IL1RN—gout	0.00256	0.0106	CbGpPWpGaD
Ruxolitinib—Skin disorder—Naproxen—gout	0.00254	0.00464	CcSEcCtD
Ruxolitinib—RET—SIDS Susceptibility Pathways—IL1RN—gout	0.0025	0.0104	CbGpPWpGaD
Ruxolitinib—Asthenia—Colchicine—gout	0.0025	0.00455	CcSEcCtD
Ruxolitinib—MAP3K3—Signaling by Interleukins—CASP1—gout	0.00247	0.0102	CbGpPWpGaD
Ruxolitinib—Alanine aminotransferase increased—Hydrocortisone—gout	0.00244	0.00444	CcSEcCtD
Ruxolitinib—MAP3K3—Signaling by Interleukins—IL1RN—gout	0.00239	0.00992	CbGpPWpGaD
Ruxolitinib—Asthenia—Indomethacin—gout	0.00237	0.00432	CcSEcCtD
Ruxolitinib—Body temperature increased—Allopurinol—gout	0.00237	0.00432	CcSEcCtD
Ruxolitinib—JAK2—IFN-gamma pathway—CASP1—gout	0.00235	0.00971	CbGpPWpGaD
Ruxolitinib—Pruritus—Indomethacin—gout	0.00234	0.00426	CcSEcCtD
Ruxolitinib—JAK3—Signaling by Interleukins—CASP1—gout	0.00233	0.00966	CbGpPWpGaD
Ruxolitinib—Alanine aminotransferase increased—Methylprednisolone—gout	0.00229	0.00417	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Naproxen—gout	0.00226	0.00412	CcSEcCtD
Ruxolitinib—JAK3—Signaling by Interleukins—IL1RN—gout	0.00226	0.00936	CbGpPWpGaD
Ruxolitinib—Fatigue—Naproxen—gout	0.00226	0.00412	CcSEcCtD
Ruxolitinib—PRKG2—Metabolism—BCKDHA—gout	0.00224	0.00927	CbGpPWpGaD
Ruxolitinib—Weight increased—Prednisolone—gout	0.00223	0.00406	CcSEcCtD
Ruxolitinib—Dizziness—Indomethacin—gout	0.00219	0.00398	CcSEcCtD
Ruxolitinib—Headache—Colchicine—gout	0.00218	0.00397	CcSEcCtD
Ruxolitinib—Weight increased—Hydrocortisone—gout	0.00217	0.00396	CcSEcCtD
Ruxolitinib—Weight decreased—Hydrocortisone—gout	0.00216	0.00394	CcSEcCtD
Ruxolitinib—Asthenia—Allopurinol—gout	0.00215	0.00392	CcSEcCtD
Ruxolitinib—Infestation NOS—Hydrocortisone—gout	0.00213	0.00388	CcSEcCtD
Ruxolitinib—Infestation—Hydrocortisone—gout	0.00213	0.00388	CcSEcCtD
Ruxolitinib—Pruritus—Allopurinol—gout	0.00212	0.00387	CcSEcCtD
Ruxolitinib—Headache—Indomethacin—gout	0.00207	0.00377	CcSEcCtD
Ruxolitinib—Body temperature increased—Naproxen—gout	0.00207	0.00377	CcSEcCtD
Ruxolitinib—Gastrointestinal haemorrhage—Prednisone—gout	0.00206	0.00375	CcSEcCtD
Ruxolitinib—GRK1—Disease—PRPS1—gout	0.00205	0.00848	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—PRPS2—gout	0.00205	0.00848	CbGpPWpGaD
Ruxolitinib—Weight increased—Methylprednisolone—gout	0.00204	0.00372	CcSEcCtD
Ruxolitinib—MAP3K2—MAPK Signaling Pathway—CASP1—gout	0.00202	0.00836	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by Interleukins—CASP1—gout	0.00201	0.00831	CbGpPWpGaD
Ruxolitinib—Infestation—Methylprednisolone—gout	0.002	0.00365	CcSEcCtD
Ruxolitinib—Infestation NOS—Methylprednisolone—gout	0.002	0.00365	CcSEcCtD
Ruxolitinib—Dizziness—Allopurinol—gout	0.00198	0.00362	CcSEcCtD
Ruxolitinib—Haemoglobin—Prednisolone—gout	0.00197	0.00359	CcSEcCtD
Ruxolitinib—Haemorrhage—Prednisolone—gout	0.00196	0.00357	CcSEcCtD
Ruxolitinib—JAK1—Signaling by Interleukins—IL1RN—gout	0.00194	0.00805	CbGpPWpGaD
Ruxolitinib—Haemoglobin—Hydrocortisone—gout	0.00192	0.0035	CcSEcCtD
Ruxolitinib—Haemorrhage—Hydrocortisone—gout	0.00191	0.00348	CcSEcCtD
Ruxolitinib—PHKG2—Metabolism—BCKDHA—gout	0.0019	0.00788	CbGpPWpGaD
Ruxolitinib—Headache—Allopurinol—gout	0.00188	0.00342	CcSEcCtD
Ruxolitinib—Asthenia—Naproxen—gout	0.00188	0.00342	CcSEcCtD
Ruxolitinib—CYP3A4—Irinotecan Pathway—ABCG2—gout	0.00186	0.00771	CbGpPWpGaD
Ruxolitinib—Pruritus—Naproxen—gout	0.00185	0.00338	CcSEcCtD
Ruxolitinib—PHKG2—Disease—PRPS1—gout	0.00185	0.00767	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—PRPS2—gout	0.00185	0.00767	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—PRPS1—gout	0.00182	0.00755	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—PRPS2—gout	0.00182	0.00755	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—HPRT1—gout	0.00182	0.00755	CbGpPWpGaD
Ruxolitinib—Alanine aminotransferase increased—Prednisone—gout	0.00181	0.00331	CcSEcCtD
Ruxolitinib—Haemoglobin—Methylprednisolone—gout	0.00181	0.00329	CcSEcCtD
Ruxolitinib—Haemorrhage—Methylprednisolone—gout	0.0018	0.00327	CcSEcCtD
Ruxolitinib—IRAK1—Apoptosis Modulation and Signaling—CASP1—gout	0.00175	0.00725	CbGpPWpGaD
Ruxolitinib—Dizziness—Naproxen—gout	0.00173	0.00316	CcSEcCtD
Ruxolitinib—Malnutrition—Hydrocortisone—gout	0.00166	0.00303	CcSEcCtD
Ruxolitinib—Neutropenia—Prednisone—gout	0.00166	0.00303	CcSEcCtD
Ruxolitinib—Headache—Naproxen—gout	0.00164	0.00299	CcSEcCtD
Ruxolitinib—Weight increased—Prednisone—gout	0.00162	0.00295	CcSEcCtD
Ruxolitinib—Weight decreased—Prednisone—gout	0.00161	0.00293	CcSEcCtD
Ruxolitinib—Malnutrition—Methylprednisolone—gout	0.00156	0.00285	CcSEcCtD
Ruxolitinib—PHKG2—Metabolism—HPRT1—gout	0.00155	0.00642	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—PRPS1—gout	0.00155	0.00642	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—PRPS2—gout	0.00155	0.00642	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by Interleukins—CASP1—gout	0.00153	0.00632	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by Interleukins—CASP1—gout	0.00148	0.00614	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—NLRP3—gout	0.00148	0.00613	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by Interleukins—IL1RN—gout	0.00148	0.00612	CbGpPWpGaD
Ruxolitinib—JAK2—Leptin signaling pathway—IL1RN—gout	0.00146	0.00603	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—LRRC16A—gout	0.00146	0.00603	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling by Interleukins—CASP1—gout	0.00144	0.00595	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by Interleukins—IL1RN—gout	0.00143	0.00594	CbGpPWpGaD
Ruxolitinib—Haemoglobin—Prednisone—gout	0.00143	0.00261	CcSEcCtD
Ruxolitinib—Haemorrhage—Prednisone—gout	0.00142	0.00259	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—gout	0.00141	0.00256	CcSEcCtD
Ruxolitinib—MAP3K7—Signaling by Interleukins—IL1RN—gout	0.00139	0.00576	CbGpPWpGaD
Ruxolitinib—Infection—Hydrocortisone—gout	0.00135	0.00246	CcSEcCtD
Ruxolitinib—Nervous system disorder—Hydrocortisone—gout	0.00133	0.00243	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—gout	0.00132	0.00241	CcSEcCtD
Ruxolitinib—Skin disorder—Hydrocortisone—gout	0.00132	0.0024	CcSEcCtD
Ruxolitinib—Infection—Methylprednisolone—gout	0.00127	0.00231	CcSEcCtD
Ruxolitinib—Nervous system disorder—Methylprednisolone—gout	0.00125	0.00228	CcSEcCtD
Ruxolitinib—Skin disorder—Methylprednisolone—gout	0.00124	0.00226	CcSEcCtD
Ruxolitinib—Malnutrition—Prednisone—gout	0.00124	0.00226	CcSEcCtD
Ruxolitinib—PRKCE—Disease—PRPS1—gout	0.0012	0.00498	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—PRPS2—gout	0.0012	0.00498	CbGpPWpGaD
Ruxolitinib—CAMK2G—Cytokine Signaling in Immune system—CASP1—gout	0.00118	0.00489	CbGpPWpGaD
Ruxolitinib—Gastrointestinal disorder—Hydrocortisone—gout	0.00117	0.00214	CcSEcCtD
Ruxolitinib—Fatigue—Hydrocortisone—gout	0.00117	0.00213	CcSEcCtD
Ruxolitinib—MAP3K3—Cytokine Signaling in Immune system—CASP1—gout	0.00115	0.00478	CbGpPWpGaD
Ruxolitinib—Anaemia—Prednisone—gout	0.00114	0.00209	CcSEcCtD
Ruxolitinib—CAMK2G—Cytokine Signaling in Immune system—IL1RN—gout	0.00114	0.00474	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by Interleukins—CASP1—gout	0.00112	0.00465	CbGpPWpGaD
Ruxolitinib—MAP3K3—Cytokine Signaling in Immune system—IL1RN—gout	0.00112	0.00463	CbGpPWpGaD
Ruxolitinib—Fatigue—Methylprednisolone—gout	0.0011	0.00201	CcSEcCtD
Ruxolitinib—JAK3—Cytokine Signaling in Immune system—CASP1—gout	0.00109	0.00451	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by Interleukins—IL1RN—gout	0.00109	0.0045	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—NLRP3—gout	0.00108	0.00445	CbGpPWpGaD
Ruxolitinib—Body temperature increased—Hydrocortisone—gout	0.00107	0.00196	CcSEcCtD
Ruxolitinib—JAK3—Cytokine Signaling in Immune system—IL1RN—gout	0.00105	0.00437	CbGpPWpGaD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—gout	0.00105	0.00191	CcSEcCtD
Ruxolitinib—MAP3K7—MAPK Signaling Pathway—CASP1—gout	0.00101	0.00418	CbGpPWpGaD
Ruxolitinib—Infection—Prednisone—gout	0.001	0.00183	CcSEcCtD
Ruxolitinib—Nervous system disorder—Prednisone—gout	0.000991	0.00181	CcSEcCtD
Ruxolitinib—Skin disorder—Prednisone—gout	0.000982	0.00179	CcSEcCtD
Ruxolitinib—Asthenia—Hydrocortisone—gout	0.000975	0.00178	CcSEcCtD
Ruxolitinib—Pruritus—Hydrocortisone—gout	0.000961	0.00175	CcSEcCtD
Ruxolitinib—JAK1—Cytokine Signaling in Immune system—CASP1—gout	0.000936	0.00388	CbGpPWpGaD
Ruxolitinib—Dizziness—Prednisolone—gout	0.00092	0.00168	CcSEcCtD
Ruxolitinib—Asthenia—Methylprednisolone—gout	0.000916	0.00167	CcSEcCtD
Ruxolitinib—JAK1—Cytokine Signaling in Immune system—IL1RN—gout	0.000907	0.00376	CbGpPWpGaD
Ruxolitinib—Pruritus—Methylprednisolone—gout	0.000903	0.00165	CcSEcCtD
Ruxolitinib—Dizziness—Hydrocortisone—gout	0.000898	0.00164	CcSEcCtD
Ruxolitinib—JAK1—Disease—PRPS2—gout	0.000873	0.00362	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—PRPS1—gout	0.000873	0.00362	CbGpPWpGaD
Ruxolitinib—Fatigue—Prednisone—gout	0.000871	0.00159	CcSEcCtD
Ruxolitinib—Headache—Prednisolone—gout	0.000871	0.00159	CcSEcCtD
Ruxolitinib—PRKCE—Immune System—NLRP3—gout	0.000863	0.00357	CbGpPWpGaD
Ruxolitinib—Headache—Hydrocortisone—gout	0.000851	0.00155	CcSEcCtD
Ruxolitinib—Dizziness—Methylprednisolone—gout	0.000844	0.00154	CcSEcCtD
Ruxolitinib—IRAK1—Innate Immune System—NLRP3—gout	0.000818	0.00339	CbGpPWpGaD
Ruxolitinib—Headache—Methylprednisolone—gout	0.000799	0.00146	CcSEcCtD
Ruxolitinib—Body temperature increased—Prednisone—gout	0.000799	0.00146	CcSEcCtD
Ruxolitinib—TYK2—Innate Immune System—NLRP3—gout	0.000794	0.00329	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—NLRP3—gout	0.00079	0.00327	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—NLRP3—gout	0.000772	0.0032	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—NLRP3—gout	0.00077	0.00319	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—NLRP3—gout	0.000728	0.00302	CbGpPWpGaD
Ruxolitinib—Asthenia—Prednisone—gout	0.000725	0.00132	CcSEcCtD
Ruxolitinib—PRKCE—Innate Immune System—CASP1—gout	0.000723	0.003	CbGpPWpGaD
Ruxolitinib—Pruritus—Prednisone—gout	0.000715	0.0013	CcSEcCtD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—CASP1—gout	0.000712	0.00295	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—CASP1—gout	0.000691	0.00286	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—IL1RN—gout	0.00069	0.00286	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—ABCG2—gout	0.000675	0.0028	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—CASP1—gout	0.00067	0.00278	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—IL1RN—gout	0.000669	0.00277	CbGpPWpGaD
Ruxolitinib—Dizziness—Prednisone—gout	0.000668	0.00122	CcSEcCtD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—IL1RN—gout	0.000649	0.00269	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—PRPS2—gout	0.000644	0.00267	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—PRPS1—gout	0.000644	0.00267	CbGpPWpGaD
Ruxolitinib—Headache—Prednisone—gout	0.000633	0.00115	CcSEcCtD
Ruxolitinib—JAK1—Immune System—NLRP3—gout	0.000626	0.00259	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—NLRP3—gout	0.000602	0.00249	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—ABCG2—gout	0.000574	0.00238	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—CASP1—gout	0.000525	0.00217	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—CASP1—gout	0.000524	0.00217	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—IL1RN—gout	0.000507	0.0021	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—PRPS1—gout	0.000488	0.00202	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—PRPS2—gout	0.000488	0.00202	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—NLRP3—gout	0.000476	0.00197	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—NLRP3—gout	0.000462	0.00191	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—NLRP3—gout	0.000448	0.00186	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—CASP1—gout	0.000421	0.00174	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—IL1RN—gout	0.000408	0.00169	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—CASP1—gout	0.000399	0.00165	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—CASP1—gout	0.000388	0.00161	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—CASP1—gout	0.000386	0.0016	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CASP1—gout	0.000377	0.00156	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—CASP1—gout	0.000376	0.00156	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—IL1RN—gout	0.000374	0.00155	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—IL1RN—gout	0.000365	0.00151	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CASP1—gout	0.000356	0.00147	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—NLRP3—gout	0.00035	0.00145	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IL1RN—gout	0.000344	0.00143	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CASP1—gout	0.000306	0.00127	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL1RN—gout	0.000296	0.00123	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CASP1—gout	0.000294	0.00122	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—POMC—gout	0.000289	0.0012	CbGpPWpGaD
Ruxolitinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000249	0.00103	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—POMC—gout	0.000249	0.00103	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—POMC—gout	0.000246	0.00102	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—POMC—gout	0.000242	0.001	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CASP1—gout	0.000233	0.000963	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—POMC—gout	0.000227	0.000941	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—POMC—gout	0.000226	0.000936	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CASP1—gout	0.000226	0.000935	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL1RN—gout	0.000225	0.000933	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CASP1—gout	0.000219	0.000907	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL1RN—gout	0.000219	0.000906	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL1RN—gout	0.000212	0.000878	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—POMC—gout	0.00021	0.000869	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—POMC—gout	0.000206	0.000851	CbGpPWpGaD
Ruxolitinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—gout	0.000202	0.000835	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—POMC—gout	0.000191	0.00079	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—POMC—gout	0.000181	0.000748	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—POMC—gout	0.000178	0.000736	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CASP1—gout	0.000171	0.000709	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL1RN—gout	0.000166	0.000686	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—POMC—gout	0.000164	0.000679	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—POMC—gout	0.000161	0.000668	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—BCKDHA—gout	0.000142	0.000587	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—POMC—gout	0.000133	0.000553	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—POMC—gout	0.000121	0.000501	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—HPRT1—gout	0.000116	0.000479	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PRPS2—gout	0.000116	0.000479	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PRPS1—gout	0.000116	0.000479	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—POMC—gout	0.000113	0.000466	CbGpPWpGaD
Ruxolitinib—CYP3A4—Biological oxidations—POMC—gout	0.000107	0.000444	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—POMC—gout	0.000101	0.000418	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—POMC—gout	9.69e-05	0.000401	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—POMC—gout	9.53e-05	0.000395	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—POMC—gout	9.17e-05	0.00038	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—POMC—gout	7.37e-05	0.000305	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—POMC—gout	7.15e-05	0.000296	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—POMC—gout	6.94e-05	0.000287	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—POMC—gout	5.42e-05	0.000224	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ABCG2—gout	4.28e-05	0.000177	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—POMC—gout	1.83e-05	7.59e-05	CbGpPWpGaD
